Overview / Abstract: |
Currently in the field of pharmacy, cardiovascular outcomes trial results are being posted online and featured on the news. Diabetes guidelines have not been updated to reflect this data and so it is up to the pharmacist to review these clinical trials and propose what the best practice would be for their patients. Clinicians are asking about the importance of cardiovascular outcomes data with the new anti-diabetic agents and it is our responsibility to educate them about the newest data available. By educating the pharmacist, they can make more meaningful recommendations to the clinician when treating patients in an evidence based manner. By doing so, the patients should stay healthy and overall, reduce cardiovascular outcomes in this patient population. Prior to this data being available, cardiovascular outcomes data was limited and so it didn’t weigh heavily on a recommendation that was made. With the publication of this new data, pharmacists will have to take into account cardiovascular outcomes when recommending a drug for additional therapy. At the completion of this activity, the participant should be able to: -List the current anti-diabetic agents and their mechanisms of action This activity is designed to meet the educational needs of pharmacists. MCPHS University is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. |
Expiration |
Apr 27, 2019 |
Discipline(s) |
Pharmacy CPE |
Format |
Online |
Cost |
12.00 |
Credits / Hours |
1 contact hour (.1 CEUs) |
Accreditation |
ACPE |
Presenters / Authors / Faculty |
Semie Durrani, PharmD | PGY-1 Pharmacy Practice Resident |
Activity Specialities / Related Topics |
Diabetes, Cardiology / Cardiovascular |
Keywords / Search Terms |
MCPHS University, pharmacy, diabetes, cardiovascular |